Printer Friendly

Comparative hepatoprotective activity of ethanolic extracts of Cuscuta australis against acetaminophen intoxication in Wistar rats.

1. Introduction

Acetaminophen (APAP) is a commonly used antipyretic analgesic drug for curing fever, headache, and other pains and is readily available without prescription. However, an overuse of acetaminophen has the potential of precipitating hepatic damage in both humans and animals [1]. The liver plays significant role in the metabolism of toxic chemicals, certain drugs, and environmental pollutants by using cytochrome P450 pathway. The latter convert acetaminophen to a highly toxic metabolite, specifically N-acetyl-p-benzoquinamine (NAPQI) which under normal conditions is readily detoxified by conjugation with glutathione (GSH) [2, 3]. Sustained overuse of acetaminophen enhanced the buildup of NAPQI which covalently bind to cellular macro molecules (proteins and DNA) to produce protein adduct that culminates in acute hepatic necrosis [4-6]. Oxidative stress is usually occasioned by increased level of this highly reactive species, NAPQI, and may contribute to the APAP hepatotoxicity via lipid peroxidation, mitochondrial damage, and ATP depletion [7]. Therefore, striking balance between reactive species and antioxidant enzymes might be a critical mechanism for ameliorating damage by oxidative stress under APAP toxicity [8]. Natural remedies from traditional plants are seen as effective and safe alternative treatments for hepatotoxicity [9].

Cuscuta australis is an annual parasitic plant that wraps around other plants for nourishment and forms the major flora of the tropical East and West Africa, Japan, and Australia [10]. C. australis is locally named "Omonigelegele" among the Southwestern inhabitant of Nigeria where the complete plant (seed and stem components) preparation holds a folkloric significance against various health challenges [11]. C. australis seed has been demonstrated to contain both kaempferol and astragalin majorly while the stem contains a high level of kaempferol [12]. In a similar study, Yen et al. [13] reported the hepatoprotective and antioxidant effects of Cuscuta chinensis against acetaminophen-induced hepatotoxicity in rats. However, there is no scientific documentation on the ameliorative potential of C. australis on acetaminophen-induced hepatotoxicity; this study seeks to investigate the possibility.

2. Materials and Methods

2.1. Chemicals. Chemicals were purchased from SigmaAldrich Chemical Co. (St. Louis, Missouri, USA): nicotinamide adenine dinucleotide phosphate (NADP); glycylglycine; glucose-6-phosphate; l-y-glutamyl-3-carboxyl-4nitronilide; epinephrine; hydrogen peroxide; glutathione (GSH); 5,50-dithio-bis-2-nitrobenzoic acid; thiobarbituric acid; and 1-chloro-2,4-dinitrobenzene. Acetaminophen was from Panadol, GlaxoSmithKline Consumer Plc. Every other reagent used was of analytic grade and was obtained from the British Drug Houses (Poole, Dorset, UK).

2.2. Plant Material Collection and Authentication. Cuscuta australis plant (seed and stem) was harvested from flower leaves within Agogo Ide compound, Abeokuta, Nigeria, and authenticated in the Department of Botany, University of Ibadan, with voucher specimen number UIH-22351.

2.3. Plant Extract Preparation. Three hundred (300 g) grams of Cuscuta australis of each sample was dried at room temperature, blended into powder, and mixed with 300 mL of ethanol using a Soxhlet extractor. The extraction runs for 6 hours allowing the extracts to mix effectively with the solvent at 20[degrees] C. The resultant filtrate was concentrated using a rotary evaporator (Bibby Sterling, Germany) to give 18.34 g residue weight of seed and 15.92 g of stem, yields of 6.11% and 5.31% (w/w), respectively.

2.4. Animal Protocol. A total of thirty-six Wistar rats (12 weeks) obtained from the experimental Animal Unit of the Faculty of Veterinary Medicine, University of Ibadan, Nigeria, were used for this study. The rats weighed between 150 and 200 g and maintained in galvanized wire mesh cages, under hygienic conditions. All animals were fed with pelletised growers mash and water ad libitum. They were acclimatized for two weeks prior to the commencement of the experiment. All rats received humane care in accordance to the "guide for the care and use of lab animals" (National Academic Press, Washington DC, USA, 1996).

2.5. Experimental Design. The modified experimental procedure of Yen et al. [13] was adopted. Rats were randomly divided into six groups, each consisting of six rats.

Group 1: served as normal control and orally received sterile water for seven days and then intraperitoneally injected with 10mL/kg body weight isotonic 0.9% NaCl.

Group 2: served as hepatoxicity control and orally given sterile water for seven days and then intraperitoneally intoxicated with 835 mg/kg body weight acetaminophen on the 8th day.

Group 3: this group was treated orally with low dose (125 mg) of C. australis seed extract for seven days and then intoxicated with 835 mg/kg acetaminophen on the 8th day.

Group 4: this group was orally given high dose (250 mg) of C. australis seed extract for seven days and then intoxicated with 835 mg/kg acetaminophen on the 8th day.

Group 5: this group was orally administered low dose (125 mg) of C. australis stem extract for seven days and then intoxicated with 835 mg/kg on the 8th day.

Group 6: this group was treated orally with high dose (250 mg) of C. australis stem extract for seven days and then intoxicated with 835 mg/kg acetaminophen on the 8th day. Acetaminophen was dissolved in 40% polyethylene glycerol 400 for administration.

After 24 hours of acetaminophen intoxication, the rats were sacrificed for the evaluation of biochemical and histological variations in the liver tissues.

2.6. Biochemical Assays. Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were estimated spectrophotometrically as described by Toro and Ackermann [14] and Duncan et al. [15]. Total bilirubin level was determined by diazo reaction [16, 17]. Six sections of liver and kidney per experimental group of rats were homogenized in 50 mM Tris-HCl buffer (pH 7.4) containing 1.15% potassium chloride. The homogenate was centrifuged at 10,000 g for 15 min at 4[degrees]C. The supernatant was collected for the estimation of superoxide dismutase (SOD) by the method described by Misra and Fridovich [18]. GSH was determined at 412 nm using the method described by Jollow et al. [19]. Glutathione peroxidase assay was determined according to the method of Rotruck [20]. Lipid peroxidation was quantified as MDA according to the method described by Farombi et al. [21] and expressed as ^m MDA/g tissue. Catalase activities were assessed by the method of Clairborne 22].

2.7. Histopathological Preparations of the Tissues. Ten percent formalin fixed liver tissues were routinely processed and stained with haematoxylin and eosin for light microscopy at x100 and x400 magnifications.

2.8. Statistical Analysis. The data was statistically analysed using one-way analysis of variance (ANOVA) and Turkey was used for multiple comparisons post hoc. The results were expressed as group mean [+ or -] standard error of mean, while the level of significance was P < 0.05.

3. Result

3.1. Histopathology. The liver of the APAP exclusively intoxicated rats showed moderate portal congestion with periportal hepatic necrosis, cellular infiltration, and foci of haemorrhage into the hepatic parenchyma. The severity of APAP damage was reduced in the liver of group that received 250 mg dose of Cuscuta australis seed pretreatment. However, normal cytoarchitecture was observed in the low dose of the seed and in both doses of Cuscuta australis stem, respectively, as shown in Figure 1.

3.2. Serological Parameters. Table 1 shows the effects of pre-treatment with C. australis against acetaminophen-induced variations on serological parameters. The hepatic injury markers, serum ALT, AST, and bilirubin levels, significantly increased (P < 0.001) in APAP-induced Group B rats relative to control. Pretreatment with 125 or 250 mg/kg extracts of C. australis seed significantly (P < 0.05 and P < 0.01, resp.) reduced the elevations. Similarly, doses of stem extract pair significantly (P < 0.05 and P < 0.001, resp.) ameliorated the elevated values in dose-dependent manner compared to exclusively APAP-intoxicated Group B rats.

3.3. Biochemical Parameters. The data on the effects of C. australis pretreatments against acetaminophen (APAP) induced antioxidant systems damage and lipid peroxidation in liver tissues (Figures 2(A)-2(D)) showed that APAP-intoxication significantly (P < 0.001) decreased the hepatic catalase (CAT), superoxide dismutase (SOD), and glutathione peroxidase (GSH-PX) enzymes of exclusively APAP-intoxicated group compared to control (Figures 2(A)-2(C)). However, levels of CAT, SOD, and GSH-PX enzymes of rats given low (125 mg) and high (250 mg) doses of C. australis seed extracts significantly (P < 0.01 and P < 0.05, resp.) increased with strong efficacy at low dose when compared to the exclusively APAP-intoxicated group (Figures 2(A)-2(C)). The profile of CAT, SOD, and GSH-PX enzymes of C. australis stem extracts was similar to its seed counterpart but a significantly (P < 0.01) dose-dependent response was observed in the stem extract pairs. The lipid peroxidation increased significantly (P < 0.001) in the APAP-intoxicated group relative to the control. The LPO level of the cotreated groups was strikingly ameliorated by varied doses of either extracts of C. australis. Although, cotreated group that received pretreatment with 400 mg dose of C. australis stem was insignificantly (P > 0.05) different from the control (Figure 2(D)).

4. Discussion

This study demonstrated that APAP-intoxication resulted in an overt hepatotoxicity as evidenced by serum elevations of ALT, AST, and bilirubins. Hepatotoxicity was also reflected in the liver as marked reduction in activities of GSH-PX, SOD, and catalase and significant elevation of lipid peroxides. The time point chosen in this work was based upon the known onset of the maximum hepatic injury induced by APAP-intoxication [13,23]. Thus, the observed hepatotoxicity effects of APAP in rats were similar to the previously reported works [4, 6, 24].

The increased hepatic enzymes (ALT and AST) are biochemical markers of acute hepatocellular injuries. Their elevated serum levels reflect the extent of hepatocellular membrane damage and leakage [25]. In the same vein, changes in the serum levels of bilirubin points to the morphological integrity of the hepatocytes [15]. In this study, the observed elevated serum hepatic enzymes and bilirubin levels that follow APAP-intoxication further establish the widely reported effects of APAP-intoxication on liver biochemical markers [6, 9, 13, 26]. In addition, histopathological lesions of periportal hepatic necrosis and cellular infiltration and foci of hemorrhage into the hepatic parenchyma further strengthened the typical hepatic biochemical markers in APAP-intoxication. These findings corroborate the documentation of Yen et al. [13] and Sabeena and Ajay [23]. Pretreatment with varied doses (125 and 250 mg) of either extracts of C. australis protects the hepatocytes morphological integrities against APAP-intoxication as shown by drastic reduction of the hepatic enzymes (ALT and AST), bilirubin levels, and improved histoarchitecture. Comparatively, the crude extract of Cuscuta australis stem offers a better dose-dependent response to this morphological integrity protection compared to its seed counterparts.

These observations are suggested to be connected to the flavonoids (antioxidative agents) contents in the seed (astragalin and kaempferol) and stem (majorly kaempferol) of C. australis as earlier reported by Ye et al. [12]. However, further studies are needed to estimate the different flavones contents of our stem and seed preparations as their levels in Cuscuta species have been reported to be influenced by the host plants [12].

Oxidativestressisamajormechanism in thedevelopment of APAP-induced hepatotoxicity [27, 28]. It is usually occasioned by increased level of highly reactive N-acetyl-p- benzoquinamine (NAPQI) in cytochrome P450 which eventually weakened antioxidant defense system [3]. Preventive antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX) are involved in direct elimination of reactive oxygen species, namely, superoxide radical and hydrogen peroxide that emanated from the disruptive effect of NAPQI [29]. SOD represents the first line of defense that assists in mopping up singlet oxygen and splitting superoxide radicals to [H.sub.2][O.sub.2]. The elimination of the latter is usually carried out by hepatic catalase which progresses the course of scavenging the hydrogen peroxide produced while glutathione peroxidase through its catalytic action on lipid peroxides prevents the formation of lipid peroxidation reaction [30]. The result on SOD, CAT, and GPX antioxidant enzymes as reflected by decreased levels of these enzymes in exclusively APAP-intoxicated rats further established the toxic potential of APAP These findings agree with popular reports of antioxidant enzymes depletion in APAP-intoxication [9,13,24]. These depletions disrupted the hepatic defense systems and thereby favor excessive accumulation of [H.sub.2][O.sub.2] which eventually weakened the system. Similarly, hepatic lipid peroxidation (LPO) level is associated with the production of superoxide radical. Therefore, the increased level of LPO in this study suggested that APAP-intoxication stimulates free radical-generating ability of the liver tissues of APAP-intoxicated rats.

Interestingly, C. australis pretreatments, most especially the stem extract, remarkably ameliorated the disrupted antioxidant defense systems in dose-dependent manner by improving the levels of APAP-intoxicated depleted antioxidant enzymes (CAT, SOD, and GPX) and quantity of LPO generated in the liver. These observed ameliorations are suggested to be linked to the phytoantioxidants constituents (astragalin and kaempferol) of C. australis and particularly the high concentration of kaempferol in the stem of C. australis. The hepatoprotective effects of C. australis observed in this study are similar to the previous report on Cuscuta chinensis [13] in a rat model of acetaminophen-induced hepatotoxicity. This is the first report on hepatoprotective effects of the stem and seed of C. australis and provides a new insight into the traditional use of this parasitic vine as a supplement for the management of liver diseases.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


The authors acknowledge the technical assistant provided by Mr. Akinkunmi Ebenezer of Longlife Diagnostic Laboratory, Ibadan.


[1] M. Mazer and J. Perrone, "Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management," Journal of Medical Toxicology, vol. 4, no. 1, pp. 2-6,2008.

[2] D. K. Mittal, D. Joshi, and S. Shukla, "Protective effects of Polygonum bistort (Linn.) and its active principle against acetaminophen-induced toxicity in rats," Asian Journal of Experimental Biological Sciences, vol. 1, pp. 951-958, 2010.

[3] D. C. Dahlin, G. T. Miwa, A. Y. H. Lu, and S. D. Nelson, "Nacetyl-p- benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen," ISOTOPENPRAXIS, vol. 20, no. 1, pp. 1327-1331,1984.

[4] N. P E. Vermeulen, J. G. M. Bessems, and R. van de Straat, "Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism-based prevention," Drug Metabolism Reviews, vol. 24, no. 3, pp. 367-407,1992.

[5] B. K. Park, M. Pirmohamed, and N. R. Kitteringham, "Idiosyncratic drug reactions: a mechanistic evaluation of risk factors," British Journal of Clinical Pharmacology, vol. 34, no. 5, pp. 377-395, 1992.

[6] M. N. Somchit, A. Zuraini, A. A. Bustaman, N. Somchit, M. R. Sulaiman, and R. Noratunlina, "Activity of tumeric (Curcuma longa) in paracetamol -induced hepatotoxicity in rats," International Journal of Pharmacology, vol. 1, no. 3, pp. 252-256, 2005.

[7] J. A. Hinson, A. B. Reid, S. S. McCullough, and L. P. James, "Acetaminophen-induced hepatotoxicity: Role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition," Drug Metabolism Reviews, vol. 36, no. 3-4, pp. 805-822, 2004.

[8] H. Jaeschke, T. R. Knight, and M. L. Bajt, "The role of oxidant stress and reactive nitrogen species in acetaminophen hepatotoxicity," Toxicology Letters, vol. 144, no. 3, pp. 279-288, 2003.

[9] S. Fakurazi, S. A. Sharifudin, and P Arulselvan, "Moringa oleifera Hydroethanolic extracts effectively alleviate acetaminophen-induced hepatotoxicity in experimental rats through their antioxidant nature," Molecules, vol. 17, no. 7, pp. 8334-8350, 2012.

[10] L. G. Maria, "Taxon description," Flora of Tropical West Africa, vol. 8, no. 1, p. 130,1987

[11] H. M. Burkill, The Useful Plants of West Tropical Africa, vol. 1, Royal Botanical Gardens Kew, 2nd edition, 1985.

[12] M. Ye, Y. Li, Y. Yan, H. Liu, and X. Ji, "Determination of flavonoids in Semen Cuscutae by RP-HPLC," Journal of Pharmaceutical and Biomedical Analysis, vol. 28, no. 3-4, pp. 621-628, 2002.

[13] F. Yen, T. Wu, L. Lin, and C. Lin, "Hepatoprotective and antioxidant effects of Cuscuta chinensis against acetaminophen-induced hepatotoxicity in rats," Journal of Ethnopharmacology, vol. 111, no. 1, pp. 123-128, 2007

[14] G. Toro and P. Ackermann, Practical Clinical Chemistry, Little Brown and Company, Boston, Mass, USA, 1st edition, 1975.

[15] J. R. Duncan, K. W. Prasse, and E. A. Mahaffey, Veterinary Laboratory Medicine: Clinical Pathology, Iowa State University Press, 3rd edition, 1994.

[16] B. Nosslin, "The direct diazo reaction of bile pigments in serum," Scandinavian Journal of Clinical and Laboratory Investigation, supplement 49, pp. 12-14,1960.

[17] M. Michealson, "Bilirubin determination in serum and urine," Scandinavian Journal of Clinical & Laboratory Investigation, supplement 56, pp. 13-21, 1961.

[18] H. P. Misra and I. Fridovich, "The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase," The Journal of Biological Chemistry, vol. 247, no. 10, pp. 3170-3175,1972.

[19] D. J. Jollow, J. R. Mitchell, N. Zampaglione, and J. R. Gillette, "Bromobenzene induced liver necrosis. Protective role of glutathione and evidence for 3,4 bromobenzene oxide as the hepatotoxic metabolite," Pharmacology, vol. 11, no. 3, pp. 151-169,1974.

[20] E. O. Farombi, J. G. Tahnteng, A. O. Agboola, J. O. Nwankwo, and G. O. Emerole, "Chemoprevention of 2acetylaminofluorene-induced hepatotoxicity and lipid peroxidation in rats by kolaviron--a Garcinia kola seed extract," Food and Chemical Toxicology, vol. 38, no. 6, pp. 535-541, 2000.

[21] J. T. Rotruck, A. L. Pope, H. E. Ganther, A. B. Swanson, D. G. Hafeman, and W. G. Hoekstra, "Selenium: biochemical role as a component of glatathione peroxidase," Science, vol. 179, no. 4073, pp. 588-590,1973.

[22] A. Clairborne, "Catalase activity," in Handbook of Methods for Oxygen Radical Research, A. R. Greewald, Ed., pp. 237-242, CRC Press, Boca Raton, Fla, USA, 1995.

[23] H. S. Sabeena and G. N. Ajay, "Hepatoprotective effect of leaves of Erythroxylum monogynum Roxb. on paracetamol induced toxicity," Asian Pacific Journal of Tropical Biomedicine, vol. 3, no. 11, pp. 877-881, 2013.

[24] A. O. Morakinyo, B. O. Iranloye, O. T. Oyelowo, and J. Nnaji, "Anti-oxidative and hepatoprotective effect of beta-carotene on acetaminophen-induced liver damage in rats," Biology and Medicine, vol. 4, no. 3, pp. 134-140, 2012.

[25] M. M. Kaplan, "Laboratory tests," in Diseases of the Liver, L. Schiff and E. R. Schiff, Eds., pp. 108-144, JB Lippinocott, Philadephia, Pa, USA, 7th edition, 1993.

[26] Y. Halil, I. Salim, C. Erdinc, and U. Bulent, "Current issues with paracetamol induced toxicity," Journal of Experimental and Integrative Medicine, vol. 1, no. 3, pp. 165-166, 2011.

[27] C.-C. Lin, M.-H. Yen, T.-S. Lo, and J.-M. Lin, "Evaluation of the hepatoprotective and antioxidant activity of Boehmeria nivea var. nivea and B. nivea var. tenacissima," Journal of Ethnopharmacology, vol. 60, no. 1, pp. 9-17, 1998.

[28] M. B. Ahmed and M. R. Khater, "Evaluation of the protective potential of Ambrosia maritima extract on acetaminophen-induced liver damage," Journal of Ethnopharmacology, vol. 75, no. 2-3, pp. 169-174, 2001.

[29] S. L. Michael, N. R. Pumford, P. R. Mayeux, M. R. Niesman, and J. A. Hinson, "Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species," Hepatology, vol. 30, no. 1, pp. 186-195,1999.

[30] H. Sies, "Strategies of antioxidant defense," European Journal of Biochemistry, vol. 215, no. 2, pp. 213-219,1993.

Rachael O. Folarin, (1) Jamiu O. Omirinde, (2) Ronald Bejide, (3) Tajudeen O. Isola, (4) Levi I. Usende, (4) and Afisu Basiru (4)

(1) College of Health Sciences, Ladoke Akintola University of Technology, Ogbomoso 4000, Nigeria

(2) Department of Veterinary Anatomy, University of Jos, Jos 930001, Nigeria

(3) Department of Morbidity and Forensic Medicine, Obafemi Awolowo University, Ile Ife A234, Nigeria

(4) Department of Veterinary Public Health, Anatomy & Physiology and Pharmacology, Ibadan 900001, Nigeria

Correspondence should be addressed to Jamiu O. Omirinde;

Received 21 March 2014; Revised 2 June 2014; Accepted 24 June 2014; Published 10 September 2014

Academic Editor: Girja S. Shukla

Table 1: Effect of Cuscuta australis extracts on
liver function markers in acetaminophen-intoxicated rats.

Treatment                 AST                        ALT

(A) Control       19.00 [+ or -] 2.86        10.80 [+ or -] 0.83
(B) APAP        93.50 [+ or -] 11.66 (a)   50.67 [+ or -] 8.68 (a)
  (865 mg)
(C) LCSD + AP   36.70 [+ or -] 3.03 (c)    19.00 [+ or -] 2.35 (c)
(D) HCSD + AP   54.87 [+ or -] 5.19 (b)    26.33 [+ or -] 3.24 (b)
(E) LCST + AP   45.83 [+ or -] 3.91 (b)    14.40 [+ or -] 1.20 (c)
(F) HCSD + AP     23.00 [+ or -] 2.28d       10.67 [+ or -] 0.99

Treatment                TBIL

(A) Control       0.33 [+ or -] 0.04
(B) APAP        1.18 [+ or -] 0.14 (a)
  (865 mg)
(C) LCSD + AP   0.54 [+ or -] 0.01 (b)
(D) HCSD + AP   0.72 [+ or -] 0.07 (b)
(E) LCST + AP   0.62 [+ or -] 0.09 (b)
(F) HCSD + AP   0.43 [+ or -] 0.04 (c)

AST: aspartate aminotransferase; ALT: alanine aminotransferase;
TBIL: total bilirubin; LCSD/HCSD: low dose (125mg)/high dose
(250 mg) of Cuscuta australis seed; LCST/HCST: low dose (125mg)
/high dose (250 mg) of Cuscuta australis stem. Values with
different superscripts are significantly different; Pvalues:
(a) P <0.001: APAP compared with normal control; (b) P <0.05,
(c) P <0.01, and AP <0.001: experimental groups compared with
COPYRIGHT 2014 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Folarin, Rachael O.; Omirinde, Jamiu O.; Bejide, Ronald; Isola, Tajudeen O.; Usende, Levi I.; Basiru
Publication:International Scholarly Research Notices
Article Type:Report
Date:Jan 1, 2014
Previous Article:Dyslipidemia in psoriasis: a case controlled study.
Next Article:Healthcare supported by data mule networks in remote communities of the Amazon region.

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |